GAS8-SPIRE2 Fusion FISH Probe
The GAS8-SPIRE2 Fusion FISH Probe is used to confirm a fusion of the GAS8 and SPIRE2 genes. The fusion of the GAS8 and SPIRE2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GAS8-SPIRE2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GAS8-SPIRE2-20-AQAQ | 20 (40 μL) | 200 μL |
|
GAS8 Gene Summary
This gene includes 11 exons spanning 25 kb and maps to a region of chromosome 16 that is sometimes deleted in breast and prostrate cancer. The second intron contains an apparently intronless gene, C16orf3, that is transcribed in the opposite orientation. This gene is a putative tumor suppressor gene. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
Gene Name: Growth Arrest Specific 8
Chromosome: CHR16: 90089007 -90111379
Locus: 16q24.3
SPIRE2 Gene Summary
The Spire Type Actin Nucleation Factor 2 (SPIRE2) gene is located on chr16 :89894906-89937727 at 16q24.3.
Gene Name: Spire Type Actin Nucleation Factor 2
Chromosome: CHR16: 89894906 -89937727
Locus: 16q24.3
Gene Diseases
The GAS8 SPIRE2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|